Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia

James R. Marshall, Wael Sakr, David Wood, Donna Berry, Catherine Tangen, Felicia Parker, Ian Thompson, Scott M. Lippman, Ronald Lieberman, David Alberts, David Jarrard, Charles Coltman, Peter Greenwald, Lori Minasian, E. David Crawford

Research output: Contribution to journalArticle

34 Scopus citations

Abstract

High-grade prostatic intraepithelial neoplasia (HGFIN) is generally regarded as a premalignant lesion that progresses toward prostate cancer. In light of the significant sequelae of prostate cancer treatment, prevention is desirable, and men with HGPIN would be suitable, high-risk subjects. There is in vitro, in vivo, epidemiologic, and human experimental evidence that selenium supplementation may protect against prostate cancer. This article introduces the rationale for, and progress to date, of a double-blind, randomized, placebo-controlled trial of selenium supplementation (200 μg/d in the form of selenomethionine), to prevent the development of prostate cancer among men with HGPIN. The trial, Southwest Oncology Group Protocol 9917, funded by a National Cancer Institute program supporting pivotal prevention trials has registered 537 patients and has randomized >380 to date. Subject accrual is expected to be completed by the fall of 2006, with trial completion in 2009.

Original languageEnglish (US)
Pages (from-to)1479-1484
Number of pages6
JournalCancer Epidemiology Biomarkers and Prevention
Volume15
Issue number8
DOIs
StatePublished - Aug 1 2006

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Fingerprint Dive into the research topics of 'Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia'. Together they form a unique fingerprint.

  • Cite this

    Marshall, J. R., Sakr, W., Wood, D., Berry, D., Tangen, C., Parker, F., Thompson, I., Lippman, S. M., Lieberman, R., Alberts, D., Jarrard, D., Coltman, C., Greenwald, P., Minasian, L., & Crawford, E. D. (2006). Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia. Cancer Epidemiology Biomarkers and Prevention, 15(8), 1479-1484. https://doi.org/10.1158/1055-9965.EPI-05-0585